Arrowhead Research ARWR Business Segments — R&D
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arrowhead Research in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arrowhead Research's business segments — r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arrowhead Research's business segments — R&D?
- Arrowhead Research (ARWR) reported business segments — R&D of $173.25M in Q1 2026.
- How has Arrowhead Research's business segments — R&D changed year-over-year?
- Arrowhead Research's business segments — R&D increased by 30.2% year-over-year, from $133.1M to $173.25M.
- What does business segments — R&D mean?
- Total cost of all research and development activities.
- How do you interpret business segments — R&D?
- Higher spending indicates a commitment to pipeline expansion, while lower spending may signal a focus on cost control or a reduction in R&D projects.
- How does business segments — R&D compare across companies?
- Standard 'Research and Development Expense' reported by all pharmaceutical and biotech companies.